In the last trading session, 24.93 million ENDRA Life Sciences Inc (NASDAQ:NDRA) shares changed hands as the company’s beta touched 0.87. With the company’s per share price at $0.03 changed hands at -$0.01 or -19.11% during last session, the market valuation stood at $2.36M. NDRA’s last price was a discount, traded about -9200.0% off its 52-week high of $2.79. The share price had its 52-week low at $0.04, which suggests the last value was -33.33% down since then. When we look at ENDRA Life Sciences Inc’s average trading volume, we note the 10-day average is 0.27 million shares, with the 3-month average coming to 23.28 million.
Analysts gave the ENDRA Life Sciences Inc (NDRA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended NDRA as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ENDRA Life Sciences Inc (NASDAQ:NDRA) trade information
Instantly NDRA was in red as seen at the end of in last trading. With action -42.10%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -98.46%, with the 5-day performance at -42.10% in the red. However, in the 30-day time frame, ENDRA Life Sciences Inc (NASDAQ:NDRA) is -57.16% down. Looking at the short shares, we see there were 0.22 million shares sold at short interest cover period of 0.03 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 48.47%. The 2024 estimates are for ENDRA Life Sciences Inc earnings to increase by 85.44%.
NDRA Dividends
ENDRA Life Sciences Inc is expected to release its next quarterly earnings report in September.
ENDRA Life Sciences Inc (NASDAQ:NDRA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.91% of ENDRA Life Sciences Inc shares while 1.04% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.08%.
Among Mutual Funds, the top two as of Jun 30, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . With 61.55 shares estimated at $2006.0 under it, the former controlled 0.08% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.05% of the shares, roughly 39.81 shares worth around $1297.0.
